Nine Researchers Honored for Outstanding Achievements at AACC Meeting
By LabMedica International staff writers Posted on 20 Jul 2012 |
AACC 2012: American Association for Clinical Chemistry (AACC; Washington DC, USA) President Greg Miller, PhD, presented nine awards at the 2012 annual meeting in Los Angeles (CA, USA).
Eric D. Green, MD, PhD received the Wallace H. Coulter Lectureship Award, which recognizes an individual whose efforts have had a profound effect on the field of clinical chemistry. He is director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) in Bethesda (MD, USA), where he is chief of its technology branch, and director of the NIH Intramural Sequencing Center.
Dr. Green has led efforts to map, sequence, and understand eukaryotic genomes. He provided important insights about genome structure, function, and evolution.
Thomas P. Moyer, PhD, received the Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine. Dr. Moyer is professor of laboratory medicine and pathology, clinical laboratory director, and senior vice president of Mayo Medical Laboratories Rochester (MN, USA). He created and directed the drug laboratory there, and has developed more than 120 diagnostic test procedures.
The AACC Award for Outstanding Contributions through Service to the Profession of Clinical Chemistry was presented to John E. Sherwin, PhD. Dr. Sherwin recently retired from his position as director of laboratory operations for Perkin Elmer Life and Analytical Sciences in (Waltham, MA, USA), where he was responsible for the genetic screening and neural tube defects laboratories.
David B. Sacks, MB, ChB won the AACC Award for Outstanding Contributions in Education. He is senior investigator, chief of the clinical chemistry service, and deputy chief of the department of laboratory medicine at the National Institutes of Health in Bethesda.
In his previous positions as associate professor of pathology at Harvard Medical School (Boston, MA, USA) and medical director of clinical chemistry at the Brigham and Women’s Hospital in Boston (MA, USA), he established and directed a residency training program in clinical pathology. During the 20 years he directed the program more than 50 residents were recruited who have become successful physician-scientists and leaders in health care.
Dr Sacks' scientific work is in the area of intracellular signal transduction, with a focus on calcium and calmodulin signaling. His primary clinical interest is in diabetes mellitus, with an emphasis on the interface between the clinical laboratory and patient care.
Yuk-Ming Dennis Lo, MD accepted the Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research, which is cosponsored by the National Academy of Clinical Biochemistry, for his paradigm-changing work in prenatal diagnostics. Dr. Lo is the director of the Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong (China) and chair of the department of chemical pathology of the same institute.
Dr. Lo and colleagues made the discovery that the DNA of the fetus can be found in the plasma of the pregnant mother. This discovery challenged the conventional wisdom that the placenta serves as a barrier between the fetal and maternal blood, and opened new possibilities for noninvasive prenatal diagnosis. Subsequently Dr. Lo elucidated the fundamental biological characteristics of the fetal DNA in the mother’s bloodstream and demonstrated that it can be used for the prenatal diagnosis of diseases and for blood group genotyping.
Dr Lo developed an approach based on molecular counting and genetic sequencing to detect fetal chromosome abnormalities. He, together with his team published the first large-scale validation of this technology for Down syndrome detection, and the technology was introduced into clinical practice. Recently, Dr. Lo demonstrated that a genetic map of the fetus could be deduced by sequencing of the pregnant mother’s plasma. His work has made prenatal testing safer for the fetus and less stressful for the mother.
The Award for Scientific Achievements by a Young Investigator went to Andy Hoofnagle, MD, PhD, assistant professor in the department of laboratory medicine at the University of Washington (Seattle). He also serves as the director of clinical mass spectrometry, director of reference lab services, and assistant director of the clinical chemistry and clinical immunology laboratories.
Dr. Hoofnagle's laboratory has helped pioneer the clinical use of immunoaffinity peptide enrichment to quantify low-abundance proteins in complex mixtures. His team has also demonstrated the potential for bottom-up proteomics approaches in the quantification of proteins in the clinical laboratory. His laboratory has developed high-throughput assays for vitamin D metabolites that have been used in population studies to quantify the cardiovascular risk associated with low vitamin D levels.
Hans Lilja, MD, PhD received the Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics. Dr. Lilja is an attending research clinical chemist in the department of laboratory medicine at Memorial Sloan-Kettering Cancer Center (New York, NY, USA), an adjunct professor in the department of laboratory medicine at Lund University (Malmö, Sweden), and a Finland Distinguished Professor at the University of Tampere (Finland).
Dr. Lilja’s discoveries involving prostate-specific antigen (PSA) led to widespread use of the PSA test as a marker for prostate cancer. His current research focuses on biomarker discovery, assay development, and clinical validation of biomarkers in population-based cohorts. His research has refined the association between PSA levels and prognosis, and identified additional markers, including a panel that can help to determine which men should have a prostate biopsy.
The Helen Free Travel Award provides financial assistance to allow a nondoctoral-level AACC member to attend an AACC meeting. The winner was Sue Lam, who is a medical technologist in the molecular diagnostics laboratory of the hospital at the University of Medicine and Dentistry of New Jersey (Newark, NJ, USA).
She contributes poster presentations at national meetings—including this AACC meeting, where Ms. Lam will present her current project on the virologic response of inner-city patients infected with Hepatitis C virus. Ms. Lam’s expertise includes a wide range of clinical laboratory technologies including several molecular diagnostics measurement procedures. She contributes poster presentations at national meetings—including this AACC meeting, where Ms. Lam will present her current project on the virological response of inner-city patients infected with Hepatitis C virus.
The AACC Past President’s Award was presented to Ann M. Gronowski, PhD a professor in the department of pathology and immunology and the department of obstetrics and gynecology at the Washington University School of Medicine in St. Louis (MO, USA). She is associate medical director of the clinical chemistry, serology, and immunology laboratories at Barnes-Jewish Hospital (St. Louis, MO, USA).
The AACC’s consumer-oriented website Lab Tests Online celebrated its 10th anniversary and the 100 millionth visitor by continuing to expand its national and international reach. The site now meets the needs of 2 million visitors a month, with 15 international sites in 12 languages.
Awards were sponsored by the Wallace H. Coulter Foundation, Abbott Diagnostics, BD Diagnostics – Preanalytical Systems, Beckman Coulter, Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics.
Related Links:
AACC
Eric D. Green, MD, PhD received the Wallace H. Coulter Lectureship Award, which recognizes an individual whose efforts have had a profound effect on the field of clinical chemistry. He is director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) in Bethesda (MD, USA), where he is chief of its technology branch, and director of the NIH Intramural Sequencing Center.
Dr. Green has led efforts to map, sequence, and understand eukaryotic genomes. He provided important insights about genome structure, function, and evolution.
Thomas P. Moyer, PhD, received the Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine. Dr. Moyer is professor of laboratory medicine and pathology, clinical laboratory director, and senior vice president of Mayo Medical Laboratories Rochester (MN, USA). He created and directed the drug laboratory there, and has developed more than 120 diagnostic test procedures.
The AACC Award for Outstanding Contributions through Service to the Profession of Clinical Chemistry was presented to John E. Sherwin, PhD. Dr. Sherwin recently retired from his position as director of laboratory operations for Perkin Elmer Life and Analytical Sciences in (Waltham, MA, USA), where he was responsible for the genetic screening and neural tube defects laboratories.
David B. Sacks, MB, ChB won the AACC Award for Outstanding Contributions in Education. He is senior investigator, chief of the clinical chemistry service, and deputy chief of the department of laboratory medicine at the National Institutes of Health in Bethesda.
In his previous positions as associate professor of pathology at Harvard Medical School (Boston, MA, USA) and medical director of clinical chemistry at the Brigham and Women’s Hospital in Boston (MA, USA), he established and directed a residency training program in clinical pathology. During the 20 years he directed the program more than 50 residents were recruited who have become successful physician-scientists and leaders in health care.
Dr Sacks' scientific work is in the area of intracellular signal transduction, with a focus on calcium and calmodulin signaling. His primary clinical interest is in diabetes mellitus, with an emphasis on the interface between the clinical laboratory and patient care.
Yuk-Ming Dennis Lo, MD accepted the Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research, which is cosponsored by the National Academy of Clinical Biochemistry, for his paradigm-changing work in prenatal diagnostics. Dr. Lo is the director of the Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong (China) and chair of the department of chemical pathology of the same institute.
Dr. Lo and colleagues made the discovery that the DNA of the fetus can be found in the plasma of the pregnant mother. This discovery challenged the conventional wisdom that the placenta serves as a barrier between the fetal and maternal blood, and opened new possibilities for noninvasive prenatal diagnosis. Subsequently Dr. Lo elucidated the fundamental biological characteristics of the fetal DNA in the mother’s bloodstream and demonstrated that it can be used for the prenatal diagnosis of diseases and for blood group genotyping.
Dr Lo developed an approach based on molecular counting and genetic sequencing to detect fetal chromosome abnormalities. He, together with his team published the first large-scale validation of this technology for Down syndrome detection, and the technology was introduced into clinical practice. Recently, Dr. Lo demonstrated that a genetic map of the fetus could be deduced by sequencing of the pregnant mother’s plasma. His work has made prenatal testing safer for the fetus and less stressful for the mother.
The Award for Scientific Achievements by a Young Investigator went to Andy Hoofnagle, MD, PhD, assistant professor in the department of laboratory medicine at the University of Washington (Seattle). He also serves as the director of clinical mass spectrometry, director of reference lab services, and assistant director of the clinical chemistry and clinical immunology laboratories.
Dr. Hoofnagle's laboratory has helped pioneer the clinical use of immunoaffinity peptide enrichment to quantify low-abundance proteins in complex mixtures. His team has also demonstrated the potential for bottom-up proteomics approaches in the quantification of proteins in the clinical laboratory. His laboratory has developed high-throughput assays for vitamin D metabolites that have been used in population studies to quantify the cardiovascular risk associated with low vitamin D levels.
Hans Lilja, MD, PhD received the Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics. Dr. Lilja is an attending research clinical chemist in the department of laboratory medicine at Memorial Sloan-Kettering Cancer Center (New York, NY, USA), an adjunct professor in the department of laboratory medicine at Lund University (Malmö, Sweden), and a Finland Distinguished Professor at the University of Tampere (Finland).
Dr. Lilja’s discoveries involving prostate-specific antigen (PSA) led to widespread use of the PSA test as a marker for prostate cancer. His current research focuses on biomarker discovery, assay development, and clinical validation of biomarkers in population-based cohorts. His research has refined the association between PSA levels and prognosis, and identified additional markers, including a panel that can help to determine which men should have a prostate biopsy.
The Helen Free Travel Award provides financial assistance to allow a nondoctoral-level AACC member to attend an AACC meeting. The winner was Sue Lam, who is a medical technologist in the molecular diagnostics laboratory of the hospital at the University of Medicine and Dentistry of New Jersey (Newark, NJ, USA).
She contributes poster presentations at national meetings—including this AACC meeting, where Ms. Lam will present her current project on the virologic response of inner-city patients infected with Hepatitis C virus. Ms. Lam’s expertise includes a wide range of clinical laboratory technologies including several molecular diagnostics measurement procedures. She contributes poster presentations at national meetings—including this AACC meeting, where Ms. Lam will present her current project on the virological response of inner-city patients infected with Hepatitis C virus.
The AACC Past President’s Award was presented to Ann M. Gronowski, PhD a professor in the department of pathology and immunology and the department of obstetrics and gynecology at the Washington University School of Medicine in St. Louis (MO, USA). She is associate medical director of the clinical chemistry, serology, and immunology laboratories at Barnes-Jewish Hospital (St. Louis, MO, USA).
The AACC’s consumer-oriented website Lab Tests Online celebrated its 10th anniversary and the 100 millionth visitor by continuing to expand its national and international reach. The site now meets the needs of 2 million visitors a month, with 15 international sites in 12 languages.
Awards were sponsored by the Wallace H. Coulter Foundation, Abbott Diagnostics, BD Diagnostics – Preanalytical Systems, Beckman Coulter, Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics.
Related Links:
AACC
Latest 2012 AACC News
- South Korea to Educate Patients About Lab Tests
- Laboratory Testing Platform for Vitamin D Assay Validated
- Mobile Blood Gas Analyzer for Hospital POC Launched
- Next Generation Automation Solution Exhibited at AACC
- Extended Range HRP Microwell Substrate Launched
- Automated, Compact, Random Access Chemistry Analyzer Featured at AACC
- IVD Market Exceeded USD 50 Billion in 2011
- Hematology Analyzers Offer Channel for Immature Platelet Fraction
- New Solutions for Health Labs Featured at Expo
- Assistant Cell Image Analyzer for Hematology Labs Released
- Blood Test Detects Patients at Risk for Diabetes
- Efficiency and Workflow Enhanced in Today’s Laboratories
- Web-Based Software Platform Manages Lab Information
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more